Though it hasn't even wrapped up clinical trials, the weight loss drug retatrutide already has a cult following.
INDIANAPOLIS — Former Indiana Attorney General Curtis Hill criticized the state’s syringe exchange program during a recent podcast interview, arguing that the initiative fails to curb drug overdoses ...
GlobalData on MSN
INCOG reveals $200m injectable drug expansion in Indiana
INCOG BioPharma Services has announced injectable drug manufacturing expansion at its Fishers facility in the US state of ...
US FDA grants 510(k) marketing clearance to Zephyrus Innovations’ VaporShield CSTD: Vancouver, BC Wednesday, December 17, 2025, 14:00 Hrs [IST] Zephyrus Innovations (Zephyrus), ...
The FDA approved Lerochol, a monthly PCSK9 inhibitor, for adults with hypercholesterolemia to reduce LDL-C levels alongside diet and exercise.
A veteran Sunshine Coast anaesthetist who stole a strong sedative from private hospitals six times – and made a further ...
In Apple TV+’s ‘Pluribus,’ the entire world is taken over by an alien virus turning them into super nice people. There are only a handful of people in the entire world who have not been affected by it ...
Zephyrus Innovations (Zephyrus), a privately-owned medical device company designing and manufacturing safety syringes and ...
Coimbatore: The rural police on Monday arrested five youths for illegally selling painkillers to youngsters to get high near ...
As of February 2025, the semaglutide injection (Ozempic, Wegovy) shortage was resolved. As a result, compounded semaglutide ...
LIB Therapeutics has scored an FDA approval for its cholesterol-lowering, third-generation PCSK9 inhibitor, lerodalcibep-liga ...
MedPage Today on MSN
Third-Generation PCSK9 Inhibitor Approved for High Cholesterol
A third-generation PCSK9 inhibitor, lerodalcibep is indicated as an adjunct to diet and exercise to reduce LDL cholesterol in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results